نتایج جستجو برای: brca2 gene promoter

تعداد نتایج: 1174704  

To evaluate the role of wild promoter of L-phenylalanine dehydrogenase (PheDH) gene, referred to as pdh, from Bacillus sphaericus in expression, cloning of pdh gene in Bacillus subtilis was performed. The whole pdh gene was cloned in pHY300PLK shuttle vector and amplified, construct (pHYDH) then transformed in B. subtilis ISW1214 and E. coli JM109. The pdh endogenous promoter presented no effec...

Journal: :Oncology reports 2010
Dominique J Bernard-Gallon Samir Satih Nassera Chalabi Nadege Rabiau Remy Bosviel Luc Fontana Yves-Jean Bignon

Breast cancer is a public health problem in the Western countries. Several studies have shown that BRCA2, like BRCA1 oncosuppressors, are strongly involved in hereditary and sporadic mammary carcinogenesis. It has also been suggested that soy has a protective effect against breast cancer in Asia and, more particularly, phytoestrogens such as daidzein and genistein. Thus, phytoestrogens may have...

Journal: :middle east journal of cancer 0
ahmad shabanizadeh department of anatomy, faculty of medicine, rafsanjan university of medical sciences, rafsanjan, iran hajar dahim department of pathology, shahid beheshti hospital, isfahan, iran reza salahshoor department of anatomy, faculty of medicine, kermanshah university of medical sciences, kermanshah, iran zahra taghipour department of anatomy, faculty of medicine, rafsanjan university of medical sciences, rafsanjan, iran mohammad mohsen taghavi department of anatomy, faculty of medicine, rafsanjan university of medical sciences, rafsanjan, iran hamidreza gafarineveh department of anatomy, faculty of medicine, rafsanjan university of medical sciences, rafsanjan, iran

background : ovarian cancer is the leading cause of death among gynecological cancers. changes in the methylation of brca1 and brca2 may be an effective mechanism for breast and ovarian cancer. this study evaluates the protein expression and methylation status of brca2 in iranian patients. methods : we assessed 60 mullerian-type ovarian cancers by methylation-specific pcr assays and immunohisto...

2014
Ana Osorio Roger L. Milne Karoline Kuchenbaecker Tereza Vaclová Guillermo Pita Rosario Alonso Paolo Peterlongo Ignacio Blanco Miguel de la Hoya Mercedes Duran Orland Díez Teresa Ramón y Cajal Irene Konstantopoulou Cristina Martínez-Bouzas Raquel Andrés Conejero Penny Soucy Lesley McGuffog Daniel Barrowdale Andrew Lee SWE-BRCA Brita Arver Johanna Rantala Niklas Loman Hans Ehrencrona Olufunmilayo I. Olopade Mary S. Beattie Susan M. Domchek Katherine Nathanson Timothy R. Rebbeck Banu K. Arun Beth Y. Karlan Christine Walsh Jenny Lester Esther M. John Alice S. Whittemore Mary B. Daly Melissa Southey John Hopper Mary B. Terry Saundra S. Buys Ramunas Janavicius Cecilia M. Dorfling Elizabeth J. van Rensburg Linda Steele Susan L. Neuhausen Yuan Chun Ding Thomas v. O. Hansen Lars Jønson Bent Ejlertsen Anne-Marie Gerdes Mar Infante Belén Herráez Leticia Thais Moreno Jeffrey N. Weitzel Josef Herzog Kisa Weeman Siranoush Manoukian Bernard Peissel Daniela Zaffaroni Giulietta Scuvera Bernardo Bonanni Frederique Mariette Sara Volorio Alessandra Viel Liliana Varesco Laura Papi Laura Ottini Maria Grazia Tibiletti Paolo Radice Drakoulis Yannoukakos Judy Garber Steve Ellis Debra Frost Radka Platte Elena Fineberg Gareth Evans Fiona Lalloo Louise Izatt Ros Eeles Julian Adlard Rosemarie Davidson Trevor Cole Diana Eccles Jackie Cook Shirley Hodgson Carole Brewer Marc Tischkowitz Fiona Douglas Mary Porteous Lucy Side Lisa Walker Patrick Morrison Alan Donaldson John Kennedy Claire Foo Andrew K. Godwin Rita Katharina Schmutzler Barbara Wappenschmidt Kerstin Rhiem Christoph Engel Alfons Meindl Nina Ditsch Norbert Arnold Hans Jörg Plendl Dieter Niederacher Christian Sutter Shan Wang-Gohrke Doris Steinemann Sabine Preisler-Adams Karin Kast Raymonda Varon-Mateeva Andrea Gehrig Dominique Stoppa-Lyonnet Olga M. Sinilnikova Sylvie Mazoyer Francesca Damiola Bruce Poppe Kathleen Claes Marion Piedmonte Kathy Tucker Floor Backes Gustavo Rodríguez Wendy Brewster Katie Wakeley Thomas Rutherford Trinidad Caldés Heli Nevanlinna Kristiina Aittomäki Matti A. Rookus Theo A. M. van Os Lizet van der Kolk J. L. de Lange Hanne E. J. Meijers-Heijboer A. H. van der Hout Christi J. van Asperen Encarna B. Gómez Garcia Nicoline Hoogerbrugge J. Margriet Collée Carolien H. M. van Deurzen Rob B. van der Luijt Peter Devilee HEBON Edith Olah Conxi Lázaro Alex Teulé Mireia Menéndez Anna Jakubowska Cezary Cybulski Jacek Gronwald Jan Lubinski Katarzyna Durda Katarzyna Jaworska-Bieniek Oskar Th. Johannsson Christine Maugard Marco Montagna Silvia Tognazzo Manuel R. Teixeira Sue Healey kConFab Investigators Curtis Olswold Lucia Guidugli Noralane Lindor Susan Slager Csilla I. Szabo Joseph Vijai Mark Robson Noah Kauff Liying Zhang Rohini Rau-Murthy Anneliese Fink-Retter Christian F. Singer Christine Rappaport Daphne Geschwantler Kaulich Georg Pfeiler Muy-Kheng Tea Andreas Berger Catherine M. Phelan Mark H. Greene Phuong L. Mai Flavio Lejbkowicz Irene Andrulis Anna Marie Mulligan Gord Glendon Amanda Ewart Toland Anders Bojesen Inge Sokilde Pedersen Lone Sunde Mads Thomassen Torben A. Kruse Uffe Birk Jensen Eitan Friedman Yael Laitman Shani Paluch Shimon Jacques Simard Douglas F. Easton Kenneth Offit Fergus J. Couch Georgia Chenevix-Trench Antonis C. Antoniou Javier Benitez

Single Nucleotide Polymorphisms (SNPs) in genes involved in the DNA Base Excision Repair (BER) pathway could be associated with cancer risk in carriers of mutations in the high-penetrance susceptibility genes BRCA1 and BRCA2, given the relation of synthetic lethality that exists between one of the components of the BER pathway, PARP1 (poly ADP ribose polymerase), and both BRCA1 and BRCA2. In th...

Journal: :Human molecular genetics 2014
Honglin Song Mine S Cicek Ed Dicks Patricia Harrington Susan J Ramus Julie M Cunningham Brooke L Fridley Jonathan P Tyrer Jennifer Alsop Mercedes Jimenez-Linan Simon A Gayther Ellen L Goode Paul D P Pharoah

The aim of this study was to estimate the contribution of deleterious mutations in BRCA1, BRCA2, MLH1, MSH2, MSH6 and PMS2 to invasive epithelial ovarian cancer (EOC) in the population. The coding sequence and splice site boundaries of all six genes were amplified in germline DNA from 2240 invasive EOC cases and 1535 controls. Barcoded fragment libraries were sequenced using the Illumina GAII o...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2007
Ilir Agalliu Erika M Kwon Daniel Zadory Laura McIntosh Joseph Thompson Janet L Stanford Elaine A Ostrander

PURPOSE Several epidemiologic studies have reported that carriers of germline mutations in the BRCA2 gene have an increased risk of prostate cancer, with the highest risk observed in men diagnosed at earlier ages. However, studies of the contribution of BRCA2 mutations to the etiology of hereditary prostate cancer (HPC) have been inconsistent. EXPERIMENTAL DESIGN To further address this issue...

Journal: :International journal of molecular and immuno oncology 2023

Mutation in homologous recombination repair (HRR) pathway is well established ovarian cancers. Multiple trials have shown variable efficacy prostate Mutations other than BRCA1/BRCA2 been recently reported We describe a unique case of an elderly male with metastatic castration-resistant cancer. He responded to hormonal therapy for 6 months but later progressed. Chemotherapy docetaxel produced se...

Journal: :iranian journal of biotechnology 2006
alireza zebarjadi

the biosynthetic pathways of saturated and unsaturated fatty acids consist of many steps controlled by various enzymes. one of the methods for improving oil quality is to change the fatty acid profile through genetic manipulation which requires isolation and characterization of the genes and other cis-acting elements, such as the promoter, involved in fatty acid biosynthesis. b-ketoacyl-coa syn...

2011

Acatalogue ofmolecular aberrations that cause ovarian cancer is critical for developing and deploying therapies thatwill improve patients’ lives. The Cancer Genome Atlas project has analysed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumo...

2011

Acatalogue ofmolecular aberrations that cause ovarian cancer is critical for developing and deploying therapies thatwill improve patients’ lives. The Cancer Genome Atlas project has analysed messenger RNA expression, microRNA expression, promoter methylation and DNA copy number in 489 high-grade serous ovarian adenocarcinomas and the DNA sequences of exons from coding genes in 316 of these tumo...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید